CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
Tempur-Pedic Mattress (2 months) +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01108718
NCT01108718N/ACompleted
CompareCT.gov

Study of Mattress Type in Fibromyalgia

Beth Israel Medical Center·interventional·Posted Apr 22, 2010·Updated Mar 10, 2017

In Brief

A clinical study evaluating Tempur-Pedic Mattress (2 months) and Control Mattress (2 months) for Fibromyalgia. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The purpose of this research study is to determine if a new mattress relieves the symptoms of fibromyalgia and improves sleep, and if this is the case, whether one type of mattress is better than the other in doing so.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFibromyalgia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 22, 2010
Enrollment StartJul 1, 2009
Primary CompletionOct 1, 2010
Study CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 16.2 years ago

Interventions

Tempur-Pedic Mattress (2 months)other

Female subjects, aged 18 years or older who have been diagnosed with fibromyalgia and do not possess any sleep disorder receiving the Tempur-Pedic mattress first, then the Control Mattress.

Control Mattress (2 months)other

Female subjects, aged 18 years or older who have been diagnosed with fibromyalgia and do not possess any sleep disorder receiving the control mattress first, then the Tempur-pedic Mattress.